The association between tumor expression of CXCL12 and the survival outcomes of patients with GC was evaluated using univariate analysis in six studies [13–15, 17, 18, 20], and with multivariate analysis in four studies [11, 12, 16, 19]. The gene discussed is CXCL12; the disease is neoplasm.